Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-13

Clinical Trial Update: A New Oral Treatment For Type II Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial of a new oral treatment for Type 2 diabetes mellitus completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2018-03-13